feed,title,long_url,short_url
Benzinga,BioXcel Therapeutics' Approved Drug For Bipolar Disorders/Schizophrenia Shows No Evidence Of Worsening Or Withdrawal In Post-Marketing Study,https://benzinga.com/general/biotech/24/06/39487491/bioxcel-therapeutics-approved-drug-for-bipolar-disordersschizophrenia-shows-no-evidence-of-worsen,https://da.gd/0F2FQM
